One of the most common uses of Scopolamine is in the treatment of postoperative nausea and vomiting caused by head trauma, and in some cases it has been prescribed to prevent nausea and vomiting caused by bariatric surgery. The anticoagulant activity of scopolamine was first described in the context of the treatment of rheumatoid arthritis. For instance, in August 2021, the U.S. AMTEAC (Army Medical Test and Evaluation Activity) carried out a clinical trial on scopolamine auto-injectors at its San Antonio training site.
In addition, the antispasmodic and laxative properties have been found useful in the treatment of constipation. Clinical studies suggest that the drug is safe and well tolerated when used for short term treatments in the treatment of minor internal and external problems such as bleeding, skin abrasions, dry mouth, itching and irritation of the ears, swelling and pain in the head, neck, chest and shoulders, diarrhea, vomiting and fever. Long-term treatments may result in the need for more aggressive treatments to prevent the drug's adverse effects on the heart, kidneys, and central nervous system. If the recommended dosage of Scopolamine is missed, alert the medical staff immediately.
Read More@ https://bit.ly/3lYxa4e
